Dr Brendan Shaw is the principal of Shawview Consulting, the former CEO of Medicines Australia and assistant director-general of the International Federation of Pharmaceutical Manufacturers and Associations. In a special comment, Dr Shaw discusses the recent focus on domestic manufacturing capability.
New industrial policy for biopharmaceutical and devices industry needs careful thought
April 17, 2020 Latest NewsNews of the DayLatest Video
New Stories
-
The 'Week in Review' - 24 January
January 24, 2025 - - Podcast -
Cabinet documents reveal decades-old focus on faster PBS listings
January 24, 2025 - - Latest News -
No probity advisor but what about a form of confidentiality deed?
January 24, 2025 - - Latest News -
CEPI backing for Vaxxas to advance needle-free thermostable mRNA vaccines
January 23, 2025 - - Latest News -
New preventive treatments could support ongoing fight against COVID
January 23, 2025 - - Latest News -
Pharmac encourages input on on multiple medicines funding proposal
January 22, 2025 - - Latest News -
Immutep completes patient enrolment for EFTISARC-NEO Phase 2 trial
January 22, 2025 - - Australian Biotech